Literature DB >> 18279661

MDR1 expression identifies human melanoma stem cells.

Gilmor I Keshet1, Itamar Goldstein, Orit Itzhaki, Karen Cesarkas, Liraz Shenhav, Arkadi Yakirevitch, Avraham J Treves, Jacob Schachter, Ninette Amariglio, Gideon Rechavi.   

Abstract

ABC transporters are often found to be inherently expressed in a wide variety of stem cells, where they provide improved protection from toxins. We found a subpopulation of human melanoma cells expressing multidrug-resistance gene product 1 (MDR1). This fraction co-expresses the ABC transporters, ABCB5 and ABCC2 in addition to the stem cell markers, nanog and human telomerase reverse transcriptase (hTERT). The clonogenicity and self-renewal capacity of MDR1(+) melanoma cells were investigated in single cell settings using the limiting dilution assay. We found that the MDR1(+) cells, isolated by FACS sorting, demonstrated a higher self-renewal capacity than the MDR1(-) fraction, a key stem cell feature. Moreover, MDR1(+) cells had higher ability to form spheres in low attachment conditions, a hallmark of cancer. In conclusion, these novel findings imply that the MDR1(+) cells represent melanoma stem cells and thus should be considered as a unique cellular target for future anti-melanoma therapies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18279661     DOI: 10.1016/j.bbrc.2008.02.022

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  51 in total

Review 1.  Cancer stem cells: a novel paradigm for cancer prevention and treatment.

Authors:  Dharmalingam Subramaniam; Satish Ramalingam; Courtney W Houchen; Shrikant Anant
Journal:  Mini Rev Med Chem       Date:  2010-05       Impact factor: 3.862

Review 2.  EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?

Authors:  Shailender Singh Kanwar; Jyoti Nautiyal; Adhip P N Majumdar
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

3.  Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel.

Authors:  Christina H Stuelten; Susan D Mertins; Johanna I Busch; Meghan Gowens; Dominic A Scudiero; Mark W Burkett; Karen M Hite; Mike Alley; Melinda Hollingshead; Robert H Shoemaker; John E Niederhuber
Journal:  Stem Cells       Date:  2010-04       Impact factor: 6.277

Review 4.  Stem cells and targeted approaches to melanoma cure.

Authors:  George F Murphy; Brian J Wilson; Sasha D Girouard; Natasha Y Frank; Markus H Frank
Journal:  Mol Aspects Med       Date:  2013-10-19

Review 5.  Cancer stem cells and their mechanism of chemo-radiation resistance.

Authors:  Yonghyun Kim; Kyeung Min Joo; Juyoun Jin; Do-Hyun Nam
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

Review 6.  Chemotherapy targeting cancer stem cells.

Authors:  Haiguang Liu; Lin Lv; Kai Yang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

Review 7.  Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?

Authors:  Nayoung Lee; Steven R Barthel; Tobias Schatton
Journal:  Lab Invest       Date:  2013-10-14       Impact factor: 5.662

8.  Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  World J Clin Oncol       Date:  2012-03-10

9.  Cancer stem cells in solid tumors: elusive or illusive?

Authors:  Yvonne Welte; James Adjaye; Hans R Lehrach; Christian Ra Regenbrecht
Journal:  Cell Commun Signal       Date:  2010-05-11       Impact factor: 5.712

Review 10.  Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.